SynthesisFrontiers in medicine2025
The effect of Hp infection on dyslipidemia in Asia and out of Asia: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Helicobacter pylori (Hp) infection is a major public health problem worldwide. Similarly, millions suffer from dyslipidemia, which is a risk factor for cardiovascular and cerebrovascular diseases. This study aimed to explore whether Hp infection affects dyslipidemia. Methods: The search databases included PubMed, Web of Science, Cochrane Library, Embase, China National Knowledge Infrastructure, Wanfang Data, Chinese sci-tech periodicals, and Sino-Med, from database construction to September 2024. Casecontrol and cross-sectional studies on Hp infections associated with dyslipidemia were included. Results and Discussion: In total, 12 casecontrol and 28 cross-sectional studies were included. The total sample size included 274,414 cases, of which 130,529 were Hp-infected and 143,885 were uninfected. Compared to uninfected patients, Hp-infected patients abnormally elevated total cholesterol (TC) [Mean Difference (MD) = 0.15, 95% Confidence Interval (CI) 0.130.17, Systematic Review Registration: identifier CRD42024626356.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.